Natus Medical Incorporated
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Natus Medical Incorporated generated cash of $63,995,000, which is more than the previous year. Cash used in financing activities reached the amount of -$60,662,000 last year. Net change in cash is therefore -$6,487,000.
Cash Flow
| 2012 | 19.39M | -62.46M | 33.41M |
|---|---|---|---|
| 2013 | 36.79M | -22.3M | 17.24M |
| 2014 | 42.14M | -10.64M | -20.91M |
| 2015 | 36.85M | -19.47M | 832K |
| 2016 | 72.68M | -53.26M | 118.41M |
| 2017 | 19.72M | -160.93M | 5.82M |
| 2018 | 33.02M | -8.38M | -49.51M |
| 2019 | 60.06M | -5.33M | -48.53M |
| 2020 | 34.42M | -12.60M | -10.87M |
| 2021 | 63.99M | -1.94M | -60.66M |
NTUS Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 82.08M | 63.29M | 56.37M | 88.95M | 213.55M | 82.46M | 66.55M | 56.10M | 23.05M | 32.81M |
Operating activities | ||||||||||
Net income | 13.17M | -16.61M | -15.67M | -22.93M | -20.29M | 42.59M | 37.92M | 32.47M | 22.87M | 3.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 28.09M | 28.11M | 30.72M | 33.86M | 30.09M | 16.87M | 15.98M | 11.75M | 12.84M | 12.61M |
Stock-based compensation expense | 14.16M | 9.56M | 8.35M | 17.05M | 9.44M | 9.00M | 6.95M | 6.06M | 6.07M | 6.42M |
| Deferred income tax benefit | 14.16M | 9.56M | 8.35M | 17.05M | 9.44M | 9.00M | 6.95M | 6.06M | 6.07M | 6.42M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -13.11M | 17.65M | 9.81M | -5.19M | -30.47M | 19.72M | -15.27M | -2.43M | 9.35M | -22.03M |
Inventories | 4.83M | 1.93M | 7.18M | -7.44M | 7.58M | -7.66M | -12.23M | -2.01M | -2.29M | 5.11M |
Accounts payable | 13.53M | -4.52M | -1.36M | 4.10M | -1.38M | -4.96M | 3.27M | -7.64M | -1.38M | 11.31M |
Cash generated by operating activities | 63.99M | 34.42M | 60.06M | 33.02M | 19.72M | 72.68M | 36.85M | 42.14M | 36.79M | 19.39M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -34.01M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -3.62M | -8.60M | -5.33M | -8.54M | -4.06M | -3.39M | -5.19M | -5.72M | -3.7M | -7.34M |
Acquisitions Net | -1M | -3.99M | 0 | 151K | -190.88M | -15.84M | -14.28M | -4.92M | -18.6M | -55.12M |
Cash generated by investing activities | -1.94M | -12.60M | -5.33M | -8.38M | -160.93M | -53.26M | -19.47M | -10.64M | -22.3M | -62.46M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -10.49M | 0 | -5.63M | -2.26M | -19.28M | -11.52M | -4.63M | 0 | 0 |
Repayments of term debt | -57.41M | -58.52M | 0 | -50M | 0 | -16M | 0 | -38.01M | -52.22M | -4.35M |
Cash used in financing activities | -60.66M | -10.87M | -48.53M | -49.51M | 5.82M | 118.41M | 832K | -20.91M | 17.24M | 33.41M |
Net Change In Cash | -6.48M | 18.78M | 6.92M | -32.57M | -124.60M | 131.08M | 15.91M | 10.45M | 33.04M | -9.75M |
Cash at end of period | 75.59M | 82.08M | 63.29M | 56.37M | 88.95M | 213.55M | 82.46M | 66.55M | 56.10M | 23.05M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |